Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

This publication has 14 references indexed in Scilit:

• High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions
  Atherosclerosis, 2003
• Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome
  The American Journal of Cardiology, 2003
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease
  Circulation, 2000
• Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
  New England Journal of Medicine, 1999
• Interval estimation for the difference between independent proportions: comparison of eleven methods
  Statistics in Medicine, 1998
• Small LDL, Atherogenic Dyslipidemia, and the Metabolic Syndrome
  Circulation, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• A sharper Bonferroni procedure for multiple tests of significance
  Biometrika, 1988